²ÝÁñÉçÇøÈë¿Ú

Email

rafee.talukder@bcm.edu

Positions

Assistant Professor

Medicine
Hematology/Oncology
²ÝÁñÉçÇøÈë¿Ú
Houston, TX US

Addresses

McNair Campus (Office)

7200 Cambridge St. STE A07.152
Houston, TX 77030
United States
Phone: (832) 957-6500
Fax: (713) 610-4596

Dan L Duncan Comprehensive Cancer Center (Clinic)

The O’Quinn Medical Tower at McNairedical Center
1919 Old Spanish Trail
Houston, TX 77054
United States
Phone: (832) 957-6500
Fax: (713) 610-4596

Education

BS from Boston College

06/2011 - Chestnut Hill, MA

MD from University of Texas Health Science Center at San Antonio Long School of Medicine

06/2016 - San Antonio, TX

Residency at ²ÝÁñÉçÇøÈë¿Ú

06/2019 - Houston

Internal Medicine

Fellowship at University of Washington/Fred Hutch Cancer Center

07/2023 - Seattle, WA

Hematology and Medical Oncology

Certifications

Board Certified in Internal Medicine

#404075

American Board of Internal Medicine

Professional Interests

• Bladder cancer
• Prostate cancer
• Kidney cancer
• Testicular cancer
• Melanoma
• Sarcoma
• Phase 1 trials

Professional Statement

Rafee Talukder, M.D is board certified in internal medicine and board eligible in hematology and medical oncology. He is a native Houstonian who went to medical school at the University of Texas Long School of Medicine in San Antonio and completed his internal medicine residency at ²ÝÁñÉçÇøÈë¿Ú. Dr. Talukder then completed his fellowship in medical oncology and hematology at University of Washington/Fred Hutch Cancer Center, where he served as a chief fellow during the second year of his training. His clinical and research focus is on genitourinary oncology (bladder cancer, prostate cancer, kidney cancer, testicular cancer) with an interest in translational research and creating and running clinical trials. World renowned clinical investigators Dr. Petros Grivas and Dr. Evan Yu served as his primary research mentors. Dr. Talukder's goal is to help build and grow the genitourinary oncology program at ²ÝÁñÉçÇøÈë¿Ú and to create and run practice-changing clinical trials. He plans on working with the multi-disciplinary genitourinary oncology group to help provide access to new and innovative clinical trials for our patients in Houston and the surrounding areas.

Websites

Selected Publications

• Makrakis D, Talukder R, Lin GI, Diamantopoulos LN, et al "." Clin Genitourin Cancer. 2022 Oct; Pubmed PMID:
• Makrakis D, Talukder R, Diamantopoulos LN, et al "." BJU Int. 2022 Nov; Pubmed PMID:
• Talukder R, Makrakis D, Lin GI, Diamantopoulos LN, et al "." Clin Genitourin Cancer. 2022 Dec; Pubmed PMID:
• Chen Y, Talukder R, Merritt BY, et al "." BMC Med Genomics. 2021 May; Pubmed PMID:

Memberships

American Society of Clinical Oncology

(07/2020)

Alpha Omega Alpha Honor Medical Society

(04/2016)